These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12227885)

  • 1. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of cyclic administration of progestagens on blood coagulation factors].
    Winkler UH; Lauck US; Ebert C; Schindler AE
    Zentralbl Gynakol; 1998; 120(1):32-7. PubMed ID: 9499549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone and other progestins in benign breast disease: an overview.
    Schindler AE
    Arch Gynecol Obstet; 2011 Feb; 283(2):369-71. PubMed ID: 20383772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of mastopathy with cyclic mastodynia: clinical results and hormone profile].
    Kubista E; Müller G; Spona J
    Gynakol Rundsch; 1986; 26(2):65-79. PubMed ID: 3525344
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?
    Griesinger G; Blockeel C; Tournaye H
    Fertil Steril; 2018 May; 109(5):756-762. PubMed ID: 29778368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia.
    Ayers JW; Gidwani GP
    Fertil Steril; 1983 Dec; 40(6):779-84. PubMed ID: 6653797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study.
    Trivedi N; Chauhan N; Vaidya V
    Gynecol Endocrinol; 2016 Aug; 32(8):667-671. PubMed ID: 26950060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease.
    Nappi C; Affinito P; Di Carlo C; Esposito G; Montemagno U
    J Endocrinol Invest; 1992 Dec; 15(11):801-6. PubMed ID: 1291593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal contraception and benign breast disease. Evaluation of a treatment protocol for chronic mastopathy with mastalgia].
    Leonardi M
    Minerva Ginecol; 1997 Jun; 49(6):271-6. PubMed ID: 9289667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project.
    Tobiassen T; Rasmussen T; Döberl A; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():159-76. PubMed ID: 6594009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study.
    Taniguchi F; Ota I; Iba Y; Toda T; Tagashira Y; Ohata Y; Kurioka H; Endo Y; Sunada H; Noma H; Azuma Y; Harada T
    J Obstet Gynaecol Res; 2019 Jan; 45(1):168-175. PubMed ID: 30246276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between the efficacy of dydrogesterone and calcium plus vitamin D in improving women's general health.
    Khajehei M; Abdali K; Tabatabaee HR
    Afr J Psychiatry (Johannesbg); 2010 Jul; 13(3):218-24. PubMed ID: 20957321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].
    Kubista E; Müller G; Spona J
    Rev Fr Gynecol Obstet; 1987 Apr; 82(4):221-7. PubMed ID: 3589362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
    Saharkhiz N; Zamaniyan M; Salehpour S; Zadehmodarres S; Hoseini S; Cheraghi L; Seif S; Baheiraei N
    Gynecol Endocrinol; 2016; 32(3):213-7. PubMed ID: 26486011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E and benign breast disease.
    Meyer EC; Sommers DK; Reitz CJ; Mentis H
    Surgery; 1990 May; 107(5):549-51. PubMed ID: 2185569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Danazol in treatment of cystic mastopathy].
    Radivojevic K
    Wien Klin Wochenschr; 1991; 103(23):710-3. PubMed ID: 1792797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.